The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos)

被引:119
作者
Adachi, JD
Ioannidis, G
Pickard, L
Berger, C
Prior, JC
Joseph, L
Hanley, DA
Olszynski, WP
Murray, TM
Anastassiades, T
Hopman, W
Brown, JP
Kirkland, S
Joyce, C
Papaioannou, A
Poliquin, S
Tenenhouse, A
Papadimitropoulos, EA
机构
[1] McMaster Univ, Dept Med, St Josephs Hosp, Hamilton, ON L8N 1Y2, Canada
[2] McGill Univ, CaMos Anal Ctr, Montreal, PQ, Canada
[3] Univ British Columbia, Dept Med Endocrinol, Vancouver, BC V5Z 1M9, Canada
[4] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[5] Univ Calgary, Dept Med, Calgary, AB, Canada
[6] Univ Saskatchewan, Dept Med, Saskatoon, SK S7N 0W0, Canada
[7] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
[8] Queens Univ, MacKenzie Hlth Serv Res Grp, Kingston, ON, Canada
[9] Univ Laval, Dept Med, Ste Foy, PQ G1K 7P4, Canada
[10] Dalhousie Univ, Dept Epidemiol & Community Hlth, Halifax, NS, Canada
[11] Mem Univ Newfoundland, Dept Med, St John, NF, Canada
[12] McGill Univ, CaMos natl Coordinating Ctr, Montreal, PQ, Canada
[13] Eli Lilly & Co, Toronto, ON, Canada
关键词
fractures; Health Utilities Index; osteoporosis; quality of life;
D O I
10.1007/s00198-003-1483-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoporotic fractures can be a major cause of morbidity. It is important to determine the impact of fractures on health-related quality of life (HRQL). A total of 3,394 women and 1,122 men 50 years of age and older, who were recruited for the Canadian Multicentre Osteoporosis Study (CaMos), participated in this cross-sectional study. Minimal trauma fractures of the hip, pelvis, spine, lower body (included upper and lower leg, knee, ankle, and foot), upper body (included arm, elbow, sternum, shoulder, and clavicle), wrist and hand (included forearm, hand, and finger), and ribs were studied. Participants with subclinical vertebral deformities were also examined. The Health Utilities Index Mark II and III Systems were used to assess HRQL. Past osteoporotic fractures varied in prevalence from 1.2% (pelvis) to 27.8% (lower body) in women and 0.3% (pelvis) to 29.3% (wrist) in men. Multivariate linear regression analyses [parameter estimates and corresponding 95% confidence intervals (CI)] indicated that minimal trauma fractures were negatively associated with HRQL and that this relationship depends on fracture type and gender. The multi-attribute scores for the Mark II system were negatively related to hip (-0.05; 95% CI: -0.09, -0.01), lower body (-0.02; 95% CI: -0.03, -0.000), and subclinical vertebral fractures (-0.02; 95% CI: -0.03, -0.00) for women. The multi-attribute scores for the Mark III system were negatively related to hip (-0.09; 95% CI: -0.14, -0.03) and rib fractures (-0.06; 95% CI: -0.11, -0.00) for women, and rib fractures (-0.06; 95% CI: -0.12, -0.00) for men. In conclusion, this study demonstrates a negative association between osteoporotic fractures and quality of life in both women and men.
引用
收藏
页码:895 / 904
页数:10
相关论文
共 44 条
[1]  
[Anonymous], CLIN ORTHOP
[2]  
[Anonymous], 1997, AM J MED
[3]  
[Anonymous], 1995, Osteoporosis: Etiology, Diagnosis, and Management
[4]   Time since vertebral fracture: An important variable concerning quality of life in patients with postmenopausal osteoporosis [J].
Begerow, B ;
Pfeifer, M ;
Pospeschill, M ;
Scholz, M ;
Schlotthauer, T ;
Lazarescu, A ;
Pollaehne, W ;
Minne, HW .
OSTEOPOROSIS INTERNATIONAL, 1999, 10 (01) :26-33
[5]  
BENGNER U, 1986, ACTA ORTHOP SCAND, V57, P2297
[6]   Reliability of an osteoporosis-targeted quality of life survey instrument for use in the community: OPTQoL [J].
Chandler, JM ;
Martin, AR ;
Girman, C ;
Ross, PD ;
Love-McClung, B ;
Lydick, E ;
Yawn, BP .
OSTEOPOROSIS INTERNATIONAL, 1998, 8 (02) :127-135
[7]   COSTS AND HEALTH-EFFECTS OF OSTEOPOROTIC FRACTURES [J].
CHRISCHILLES, E ;
SHIREMAN, T ;
WALLACE, R .
BONE, 1994, 15 (04) :377-386
[8]   RECOMMENDATIONS FOR THE REGISTRATION OF NEW CHEMICAL ENTITIES USED IN THE PREVENTION AND TREATMENT OF OSTEOPOROSIS [J].
COMPSTON, JE ;
REGINSTER, JY ;
JONES, EA ;
KAUFMAN, JM ;
AUDRAN, M ;
BOUVENOT, G ;
FRATI, L ;
MAZZUOLI, G ;
GENNARI, C ;
LEMMEL, EM ;
RINGE, JD ;
SEBERT, JL ;
VANHAELST, L ;
AVOUAC, B .
CALCIFIED TISSUE INTERNATIONAL, 1995, 57 (04) :247-250
[9]  
Cook DJ, 1997, OSTEOPOROSIS INT, V7, P478
[10]  
Cranney A, 2001, J RHEUMATOL, V28, P132